Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Jeetinder Singh Mahal Insider Profile
4 Followers
Jeetinder Singh Mahal, COO at Jasper Therapeutics, holds 25.01K shares in Jasper Therapeutics (Ticker: JSPR).
Jeetinder Singh Mahal has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Jeetinder Singh Mahal's holdings
Insider Roles
COO
Roles that Jeetinder Singh Mahal holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Jeetinder Singh Mahal
Jeetinder Singh Mahal's Trading History
List of latest transactions for each holding click on a transaction to see Jeetinder Singh Mahal's performance on stock
You May Also Like
Jeetinder Singh Mahal insider profile FAQ
What is the percentage of profitable transactions made by Jeetinder Singh Mahal?
The percentage of profitable transactions made by Jeetinder Singh Mahal is ―.
What is the average return per transaction made by Jeetinder Singh Mahal?
The average return per transaction made by Jeetinder Singh Mahal is ―.
What stocks does Jeetinder Singh Mahal hold?
Jeetinder Singh Mahal holds: JSPR stocks.
What was Jeetinder Singh Mahal’s latest transaction?
Jeetinder Singh Mahal latest transaction was an Uninformative Buy of $6.39K.
What was Jeetinder Singh Mahal's most profitable transaction?
Jeetinder Singh Mahal’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Jeetinder Singh Mahal's role in Jasper Therapeutics?
Jeetinder Singh Mahal's role in Jasper Therapeutics is COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.